Delivery Order SPE2DB22D1106-SPE2DB24FDLL1
- Not listed
- This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $37,989.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,154.11, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $3,348.92, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $7,763.13, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 IDC running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $24,488.75, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 17, 2023, with an ultimate completion date of August 18, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $71,779.70, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 14, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The $8,595.80 firm fixed-price contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical...
- This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,318.34, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order, with a period of performance through March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $26,135.44 and is a firm fixed price delivery order contract that runs through April 25, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The $15,778.52 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on October 25, 2024. The contract has an ultimate completion date of October 28, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDLL1Delivery Order
This federal contract award is for the delivery of Jardiance 25 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $15,264.76 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating it was open competition. AmerisourceBergen, a for-profit organization, is the prime contractor with no major subcontractors mentioned. The contract supports the DLA's mission of providing medical products and supplies to the U.S. military and other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 11/9/23 |